768
Views
41
CrossRef citations to date
0
Altmetric
Clinical Research

Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA

ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, , & ORCID Icon show all
Pages 404-411 | Received 19 Jun 2017, Accepted 10 Oct 2017, Published online: 26 Oct 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Michaela J. Sommer, Sebastian Halter, Verena Angerer, Volker Auwärter, Florian Eyer, Gesine Liebetrau, Martin Ebbecke & Maren Hermanns-Clausen. (2022) Effect of new legislation in Germany on prevalence and harm of synthetic cannabinoids. Clinical Toxicology 60:10, pages 1130-1138.
Read now
Alex F. Manini, Alex J. Krotulski, Jonathan Schimmel, Lisa Allen, Yasmin L. Hurd, Lynne D. Richardson, Kavey Vidal & Barry K. Logan. (2022) Respiratory failure in confirmed synthetic cannabinoid overdose. Clinical Toxicology 60:4, pages 524-526.
Read now
László Institóris, Katalin Kovács, Éva Sija, Róbert Berkecz, Tímea Körmöczi, István Németh, István Elek, Ágnes Bakos, Ildikó Urbán, Csaba Pap & Éva Kereszty. (2022) Clinical symptoms and blood concentration of new psychoactive substances (NPS) in intoxicated and hospitalized patients in the Budapest region of Hungary (2018-19). Clinical Toxicology 60:1, pages 18-24.
Read now
Valérie Proulx & Benoit Tousignant. (2021) Drugs of abuse and ocular effects. Clinical and Experimental Optometry 104:5, pages 567-578.
Read now
Piotr Adamowicz. (2021) Blood concentrations of synthetic cannabinoids. Clinical Toxicology 59:3, pages 246-251.
Read now
Priyanka Parajuli, Manjari Rani Regmi, Odalys Estefania Lara-Garcia, Ismael Abu Limon & Alan Deckard. (2020) Man vs. man-made marijuana: A case of drug-induced posterior reversible encephalopathy syndrome (PRES) due to K2, a synthetic cannabinoid (SCB). Journal of Community Hospital Internal Medicine Perspectives 10:4, pages 361-364.
Read now
A. J. Potts, C. Cano, S. H. L. Thomas & S. L. Hill. (2020) Synthetic cannabinoid receptor agonists: classification and nomenclature. Clinical Toxicology 58:2, pages 82-98.
Read now
Nicholas E. Webb, David M. Wood, Shaun L. Greene, Laura J. Hunter, John R. H. Archer, Alison M. Dines & Paul I. Dargan. (2019) Change in the new psychoactive substances associated with Emergency Department acute toxicity presentations associated with the introduction of the UK 2016 Psychoactive Substances Act. Clinical Toxicology 57:1, pages 36-41.
Read now

Articles from other publishers (33)

Monica Patel, Natasha L. Grimsey, Samuel D. Banister, David B. Finlay & Michelle Glass. (2023) Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB 2 receptor . Pharmacology Research & Perspectives 11:6.
Crossref
Daniela-Mădălina Ciucă Anghel, Gabriela Viorela Nițescu, Andreea-Taisia Tiron, Claudia Maria Guțu & Daniela Luiza Baconi. (2023) Understanding the Mechanisms of Action and Effects of Drugs of Abuse. Molecules 28:13, pages 4969.
Crossref
Mariana Campello de Oliveira, Mariana Capelo Vides, Dângela Layne Silva Lassi, Julio Torales, Antonio Ventriglio, Henrique Silva Bombana, Vilma Leyton, Cintia de Azevedo-Marques Périco, André Brooking Negrão, André Malbergier & João Maurício Castaldelli-Maia. (2023) Toxicity of Synthetic Cannabinoids in K2/Spice: A Systematic Review. Brain Sciences 13:7, pages 990.
Crossref
Eric Sparkes, Rochelle Boyd, Shuli Chen, Jack W. Markham, Jia Lin Luo, Tahira Foyzun, Humayra Zaman, Charlotte Fletcher, Ross Ellison, Iain S. McGregor, Marina J. Santiago, Felcia Lai, Roy R. Gerona, Mark Connor, David E. Hibbs, Elizabeth A. Cairns, Michelle Glass, Adam Ametovski & Samuel D. Banister. (2022) Synthesis and pharmacological evaluation of newly detected synthetic cannabinoid receptor agonists AB-4CN-BUTICA, MMB-4CN-BUTINACA, MDMB-4F-BUTICA, MDMB-4F-BUTINACA and their analogs. Frontiers in Psychiatry 13.
Crossref
Sam Craft, Michael Dunn, Dan Vidler, Jane Officer, Ian S. Blagbrough, Christopher R. Pudney, Graeme Henderson, Ahmed Abouzeid, Paul I. Dargan, Michael Eddleston, Jamie Cooper, Simon L. Hill, Clair Roper, Tom P. Freeman & Simon H. L. Thomas. (2022) Trends in hospital presentations following analytically confirmed synthetic cannabinoid receptor agonist exposure before and after implementation of the 2016 UK Psychoactive Substances Act. Addiction.
Crossref
Eef Lien Theunissen, Kim Paula Colette Kuypers, Natasha Leigh Mason & Johannes Gerardus Ramaekers. (2022) A Comparison of Acute Neurocognitive and Psychotomimetic Effects of a Synthetic Cannabinoid and Natural Cannabis at Psychotropic Dose Equivalence. Frontiers in Psychiatry 13.
Crossref
Richard C. Kevin, Somayeh Mirlohi, Jamie J. Manning, Rochelle Boyd, Elizabeth A. Cairns, Adam Ametovski, Felcia Lai, Jia Lin Luo, William Jorgensen, Ross Ellison, Roy R. Gerona, David E. Hibbs, Iain S. McGregor, Michelle Glass, Mark Connor, Chris Bladen, Gerald W. Zamponi & Samuel D. Banister. (2022) Putative Synthetic Cannabinoids MEPIRAPIM, 5F-BEPIRAPIM (NNL-2), and Their Analogues Are T-Type Calcium Channel (Ca V 3) Inhibitors . ACS Chemical Neuroscience 13:9, pages 1395-1409.
Crossref
Eef L. Theunissen, Johannes T. Reckweg, Nadia R. P. W. Hutten, Kim P. C. Kuypers, Stefan W. Toennes, Merja A. Neukamm, Sebastian Halter & Johannes G. Ramaekers. (2021) Psychotomimetic symptoms after a moderate dose of a synthetic cannabinoid (JWH-018): implications for psychosis. Psychopharmacology 239:5, pages 1251-1261.
Crossref
Franziska Gaunitz & Hilke Andresen-Streichert. (2021) Analytical findings in a non-fatal intoxication with the synthetic cannabinoid 5F-ADB (5F-MDMB-PINACA): a case report. International Journal of Legal Medicine 136:2, pages 577-589.
Crossref
Nicolas Gilbert, Andrew Costello, Jamie R. Ellison, Umer Khan, Mark Knight, Michael J. Linnell, Robert Ralphs, Ryan E. Mewis & Oliver B. Sutcliffe. (2021) Synthesis, characterisation, detection and quantification of a novel hexyl-substituted synthetic cannabinoid receptor agonist: (S)-N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-hexyl-1H-indazole-3-carboxamide (ADB-HINACA). Forensic Chemistry 26, pages 100354.
Crossref
Astrid Coronado-Álvarez, Karen Romero-Cordero, Lorena Macías-Triana, Agnes Tatum-Kuri, Alba Vera-Barrón, Henning Budde, Sérgio Machado, Tetsuya Yamamoto, Claudio Imperatori & Eric Murillo-Rodríguez. (2021) The synthetic CB1 cannabinoid receptor selective agonists: Putative medical uses and their legalization. Progress in Neuro-Psychopharmacology and Biological Psychiatry 110, pages 110301.
Crossref
Jinzhao Yang, Guowu Zeng, Jianshe Ma, Xianqin Wang & Quan Zhou. (2021) Pharmacokinetics of 10-Hydroxy Mesaconitine in Rat Plasma by Ultra-Performance Liquid Chromatography-Tandem Quadrupole Mass Spectrometry. Journal of Analytical Methods in Chemistry 2021, pages 1-6.
Crossref
Chris Bladen, Somayeh Mirlohi, Marina Santiago, Mitchell Longworth, Michael Kassiou, Sam Banister & Mark Connor. (2021) Modulation of human T-type calcium channels by synthetic cannabinoid receptor agonists in vitro. Neuropharmacology 187, pages 108478.
Crossref
Monica Patel, David B. Finlay & Michelle Glass. (2021) Biased agonism at the cannabinoid receptors – Evidence from synthetic cannabinoid receptor agonists. Cellular Signalling 78, pages 109865.
Crossref
Arianna Giorgetti, Lukas Mogler, Sebastian Halter, Belal Haschimi, Andreas Alt, Daniel Rentsch, Bea Schmidt, Vanessa Thoma, Susanne Vogt & Volker Auwärter. (2019) Four cases of death involving the novel synthetic cannabinoid 5F-Cumyl-PEGACLONE. Forensic Toxicology 38:2, pages 314-326.
Crossref
Arianna Giorgetti, Francesco Paolo Busardò, Roberta Tittarelli, Volker Auwärter & Raffaele Giorgetti. (2020) Post-Mortem Toxicology: A Systematic Review of Death Cases Involving Synthetic Cannabinoid Receptor Agonists. Frontiers in Psychiatry 11.
Crossref
Carlo Alessandro Locatelli, Davide Lonati & Valeria Margherita Petrolini. 2020. Brain and Heart Dynamics. Brain and Heart Dynamics 1 27 .
Carlo Alessandro Locatelli, Davide Lonati & Valeria Margherita Petrolini. 2020. Brain and Heart Dynamics. Brain and Heart Dynamics 843 868 .
Elise Wouters, Jolien Walraed, Samuel D. Banister & Christophe P. Stove. (2019) Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists. Biochemical Pharmacology 169, pages 113623.
Crossref
Herbert Desel. (2019) Vergiftungsdokumentation und ‑berichterstattung in DeutschlandPoisoning documentation and reporting in Germany. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 62:11, pages 1287-1294.
Crossref
Abdullah Al-Matrouk, Mahasen Alqallaf, Adel AlShemmeri & Haider BoJbarah. (2019) Identification of synthetic cannabinoids that were seized, consumed, or associated with deaths in Kuwait in 2018 using GC–MS and LC–MS-MS analysis. Forensic Science International 303, pages 109960.
Crossref
Sean D. McCann & Sean M. Bryant. (2019) ADB-FUBINACA Body Packer. The Journal of Emergency Medicine 57:3, pages 397.
Crossref
Sarah Ann R. Anderson, Anna M. OprescuDiane P. Calello, Andrew Monte, Peter S. DayanYasmin L. HurdAlex F. Manini. (2019) Neuropsychiatric Sequelae in Adolescents With Acute Synthetic Cannabinoid Toxicity. Pediatrics 144:2.
Crossref
Elise Wouters, Lukas Mogler, Annelies Cannaert, Volker Auwärter & Christophe Stove. (2019) Functional evaluation of carboxy metabolites of synthetic cannabinoid receptor agonists featuring scaffolds based on L‐valine or L‐ tert ‐leucine . Drug Testing and Analysis 11:8, pages 1183-1191.
Crossref
Kyoko Hataoka, Asuka Kaizaki-Mitsumoto, Mika Takebayashi-Ohsawa, Natsumi Hattori, Masahiko Funada & Satoshi Numazawa. (2019) Hyperreflexia induced by XLR-11 smoke is caused by the pyrolytic degradant. Forensic Toxicology 37:2, pages 412-423.
Crossref
Richard C. Kevin, Lyndsey Anderson, Iain S. McGregor, Rochelle Boyd, Jamie J. Manning, Michelle Glass, Mark Connor & Samuel D. Banister. (2019) CUMYL-4CN-BINACA Is an Efficacious and Potent Pro-Convulsant Synthetic Cannabinoid Receptor Agonist. Frontiers in Pharmacology 10.
Crossref
Eike Blohm, Peter Sell & Mark Neavyn. (2019) Cannabinoid toxicity in pediatrics. Current Opinion in Pediatrics 31:2, pages 256-261.
Crossref
Azita Alipour, Puja Baldev Patel, Zaheera Shabbir & Stephen Gabrielson. (2019) Review of the many faces of synthetic cannabinoid toxicities. Mental Health Clinician 9:2, pages 93-99.
Crossref
Sebastian Halter, Verena Angerer, Jörg Röhrich, Olwen Groth, Gabriele Roider, Maren Hermanns-Clausen & Volker Auwärter. (2019) Cumyl-PEGACLONE: A comparatively safe new synthetic cannabinoid receptor agonist entering the NPS market?. Drug Testing and Analysis 11:2, pages 347-349.
Crossref
Nicholas Nacca, Rachel Schult, Robert Loflin, Adam Weltler, Rachel Gorodetsky, Sherri Kacinko, Jeffery Moran, Alex Krotulski & Timothy Wiegand. (2018) Coma, Seizures, Atrioventricular Block, and Hypoglycemia in an ADB-FUBINACA Body-Packer. The Journal of Emergency Medicine 55:6, pages 788-791.
Crossref
Franziska Gaunitz, Sabrina Lehmann, Andreas Thomas, Mario Thevis, Markus A. Rothschild & Katja Mercer-Chalmers-Bender. (2018) Post-mortem distribution of the synthetic cannabinoid MDMB-CHMICA and its metabolites in a case of combined drug intoxication. International Journal of Legal Medicine 132:6, pages 1645-1657.
Crossref
Hannah R. Fudin, Jennifer L. Babin, Lisa T. Hong, Jennifer Ku, Alisyn L. May, Alexander Wisner, F. Scott Hall & Sidhartha D. Ray. 2018. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions 29 89 .
Simon L. Hill & Paul I. Dargan. 2018. New Psychoactive Substances. New Psychoactive Substances 475 494 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.